At least 10.7 million American women use oral contraceptives (OCs). The potential connection with breast cancer has caused concern among these OC users and uncertainty among many of their physicians. This new volume offers the most up-to-date information available on this critical topic.
While the best available knowledge does not support any fundamental change in clinical practice with respect to the use of OCs, this book offers specific recommendations for more research to fully resolve the relationship between OCs and breast cancer. Noting consumer confusion, the volume includes a concise summary of benefits, risks, and other practical information for contraceptive users and their doctors.
The volume presents current data on changes in patterns of OC use, differences in risk at different ages, the benefits of OCs, and more.
Oral Contraceptives and Breast Cancer will be important reading for obstetricians/gynecologists and other health professionals, their patients who use OCs, contraceptive manufacturers, women's health advocates, policymakers, and researchers.
Table of Contents
|1. Introduction and Overview||9-24|
|2. Epidemiology: Information Needs and Data Gaps||25-34|
|3. Biology: Information Needs and Data Gaps||35-54|
|4. Information for Users of the Pill and Health Care Providers||55-60|
|5. Policy Issues and Recommendations||61-67|
|Appendix A: Oral Contraceptives and Breast Cancer: A Review of the Epidemiological Evidence with an Emphasis on Younger Women||73-101|
|Appendix B: Oral Contraceptives and Breast Cancer: Review of the Epidemiological Literature||102-142|
|Appendix C: The Evolving Formulations of Oral Contraceptives||143-151|
|Appendix D: Animal Models of Sex Steroid Hormones and Mammary Cancer: Lessons for Understanding Studies in Humans||152-164|
|Appendix E: Risks and Benefits of Oral Contraceptives: Will Breast Cancer Tip the Balance?||165-174|
|Appendix F: List of Background Documents||175-176|
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
Loading stats for Oral Contraceptives and Breast Cancer...